{"id":20333,"date":"2024-01-19T12:01:16","date_gmt":"2024-01-19T11:01:16","guid":{"rendered":"https:\/\/synektik.com.pl\/?p=20333"},"modified":"2025-01-02T12:06:16","modified_gmt":"2025-01-02T11:06:16","slug":"synektik-shares-the-profits-with-the-shareholders","status":"publish","type":"post","link":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/","title":{"rendered":"Synektik shares the profits with the shareholders"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">The Management Board recommends that the shareholders adopt a resolution regarding sharing the profits achieved in 2022 financial year and a dividend payment. The owners of the company would receive PLN 3,03 per share.<\/h2>\n\n\n\n<p>The Management Board of Synektik are recommending that the amount of PLN 25,8M of the net unit profit is assigned for the dividend payment.\u00a0 In accordance with the recommendation, the date when the rights to dividend are acquired is to be 4<sup>th<\/sup> March 2024, and the dividend payment is to take place on 8<sup>th<\/sup> March 2024. <\/p>\n\n\n\n<p>The final decision regarding the profit share is to be taken by the Ordinary General Shareholders Meeting.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/synektik.com.pl\/centrum-inwestora\/raporty-biezace\/\" target=\"_blank\" rel=\"noreferrer noopener\">Please see the report ESPI 4\/2024<\/a><\/div>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Management Board recommends that the shareholders adopt a resolution regarding sharing the profits achieved in 2022 financial year and a dividend payment. The owners of the company would receive PLN 3,03 per share. The Management Board of Synektik are recommending that the amount of PLN 25,8M of the net unit profit is assigned for [&hellip;]<\/p>\n","protected":false},"author":17,"featured_media":14108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[247,248],"tags":[],"class_list":["post-20333","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investor-relations","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Synektik shares the profits with the shareholders - Synektik<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Synektik shares the profits with the shareholders - Synektik\" \/>\n<meta property=\"og:description\" content=\"The Management Board recommends that the shareholders adopt a resolution regarding sharing the profits achieved in 2022 financial year and a dividend payment. The owners of the company would receive PLN 3,03 per share. The Management Board of Synektik are recommending that the amount of PLN 25,8M of the net unit profit is assigned for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Synektik\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Synektik\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-19T11:01:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-02T11:06:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"jstefanska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@synektik1\" \/>\n<meta name=\"twitter:site\" content=\"@synektik1\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/\"},\"author\":{\"name\":\"jstefanska\",\"@id\":\"https:\/\/synektik.jcd.pl\/#\/schema\/person\/674e6cb0be4d783919e89d982c8f53f2\"},\"headline\":\"Synektik shares the profits with the shareholders\",\"datePublished\":\"2024-01-19T11:01:16+00:00\",\"dateModified\":\"2025-01-02T11:06:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/\"},\"wordCount\":115,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/synektik.jcd.pl\/#organization\"},\"image\":{\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg\",\"articleSection\":[\"Investor relations\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/\",\"url\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/\",\"name\":\"Synektik shares the profits with the shareholders - Synektik\",\"isPartOf\":{\"@id\":\"https:\/\/synektik.jcd.pl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg\",\"datePublished\":\"2024-01-19T11:01:16+00:00\",\"dateModified\":\"2025-01-02T11:06:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#primaryimage\",\"url\":\"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg\",\"contentUrl\":\"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg\",\"width\":2560,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/synektik.jcd.pl\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Synektik shares the profits with the shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/synektik.jcd.pl\/#website\",\"url\":\"https:\/\/synektik.jcd.pl\/\",\"name\":\"Synektik\",\"description\":\"Grupa Synektik jest wiod\u0105cym producentem zaawansowanych produkt\u00f3w radiofarmaceutycznych oraz rozwi\u0105za\u0144 informatycznych, dostawc\u0105 us\u0142ug serwisowo-pomiarowych oraz dystrybutorem innowacyjnych urz\u0105dze\u0144 medycznych, stosowanych w diagnostyce oraz terapii w dziedzinach radiologii, onkologii, kardiologii i neurologii.\",\"publisher\":{\"@id\":\"https:\/\/synektik.jcd.pl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/synektik.jcd.pl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/synektik.jcd.pl\/#organization\",\"name\":\"Synektik Group\",\"url\":\"https:\/\/synektik.jcd.pl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/synektik.jcd.pl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/synektik.com.pl\/wp-content\/uploads\/2024\/07\/synektik-logo.png\",\"contentUrl\":\"https:\/\/synektik.com.pl\/wp-content\/uploads\/2024\/07\/synektik-logo.png\",\"width\":675,\"height\":675,\"caption\":\"Synektik Group\"},\"image\":{\"@id\":\"https:\/\/synektik.jcd.pl\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Synektik\/\",\"https:\/\/x.com\/synektik1\",\"https:\/\/www.linkedin.com\/company\/synektik\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/synektik.jcd.pl\/#\/schema\/person\/674e6cb0be4d783919e89d982c8f53f2\",\"name\":\"jstefanska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/synektik.jcd.pl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d3ba4e857dfc2b5dada99a4ae350c100?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d3ba4e857dfc2b5dada99a4ae350c100?s=96&d=mm&r=g\",\"caption\":\"jstefanska\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Synektik shares the profits with the shareholders - Synektik","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Synektik shares the profits with the shareholders - Synektik","og_description":"The Management Board recommends that the shareholders adopt a resolution regarding sharing the profits achieved in 2022 financial year and a dividend payment. The owners of the company would receive PLN 3,03 per share. The Management Board of Synektik are recommending that the amount of PLN 25,8M of the net unit profit is assigned for [&hellip;]","og_url":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/","og_site_name":"Synektik","article_publisher":"https:\/\/www.facebook.com\/Synektik\/","article_published_time":"2024-01-19T11:01:16+00:00","article_modified_time":"2025-01-02T11:06:16+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg","type":"image\/jpeg"}],"author":"jstefanska","twitter_card":"summary_large_image","twitter_creator":"@synektik1","twitter_site":"@synektik1","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#article","isPartOf":{"@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/"},"author":{"name":"jstefanska","@id":"https:\/\/synektik.jcd.pl\/#\/schema\/person\/674e6cb0be4d783919e89d982c8f53f2"},"headline":"Synektik shares the profits with the shareholders","datePublished":"2024-01-19T11:01:16+00:00","dateModified":"2025-01-02T11:06:16+00:00","mainEntityOfPage":{"@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/"},"wordCount":115,"commentCount":0,"publisher":{"@id":"https:\/\/synektik.jcd.pl\/#organization"},"image":{"@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg","articleSection":["Investor relations","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/","url":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/","name":"Synektik shares the profits with the shareholders - Synektik","isPartOf":{"@id":"https:\/\/synektik.jcd.pl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#primaryimage"},"image":{"@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg","datePublished":"2024-01-19T11:01:16+00:00","dateModified":"2025-01-02T11:06:16+00:00","breadcrumb":{"@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#primaryimage","url":"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg","contentUrl":"https:\/\/synektik.jcd.pl\/wp-content\/uploads\/2023\/08\/stock3-scaled.jpg","width":2560,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/synektik.jcd.pl\/en\/synektik-shares-the-profits-with-the-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/synektik.jcd.pl\/en\/"},{"@type":"ListItem","position":2,"name":"Synektik shares the profits with the shareholders"}]},{"@type":"WebSite","@id":"https:\/\/synektik.jcd.pl\/#website","url":"https:\/\/synektik.jcd.pl\/","name":"Synektik","description":"Grupa Synektik jest wiod\u0105cym producentem zaawansowanych produkt\u00f3w radiofarmaceutycznych oraz rozwi\u0105za\u0144 informatycznych, dostawc\u0105 us\u0142ug serwisowo-pomiarowych oraz dystrybutorem innowacyjnych urz\u0105dze\u0144 medycznych, stosowanych w diagnostyce oraz terapii w dziedzinach radiologii, onkologii, kardiologii i neurologii.","publisher":{"@id":"https:\/\/synektik.jcd.pl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/synektik.jcd.pl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/synektik.jcd.pl\/#organization","name":"Synektik Group","url":"https:\/\/synektik.jcd.pl\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/synektik.jcd.pl\/#\/schema\/logo\/image\/","url":"https:\/\/synektik.com.pl\/wp-content\/uploads\/2024\/07\/synektik-logo.png","contentUrl":"https:\/\/synektik.com.pl\/wp-content\/uploads\/2024\/07\/synektik-logo.png","width":675,"height":675,"caption":"Synektik Group"},"image":{"@id":"https:\/\/synektik.jcd.pl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Synektik\/","https:\/\/x.com\/synektik1","https:\/\/www.linkedin.com\/company\/synektik\/"]},{"@type":"Person","@id":"https:\/\/synektik.jcd.pl\/#\/schema\/person\/674e6cb0be4d783919e89d982c8f53f2","name":"jstefanska","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/synektik.jcd.pl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d3ba4e857dfc2b5dada99a4ae350c100?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d3ba4e857dfc2b5dada99a4ae350c100?s=96&d=mm&r=g","caption":"jstefanska"}}]}},"_links":{"self":[{"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/posts\/20333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/comments?post=20333"}],"version-history":[{"count":1,"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/posts\/20333\/revisions"}],"predecessor-version":[{"id":20334,"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/posts\/20333\/revisions\/20334"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/media\/14108"}],"wp:attachment":[{"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/media?parent=20333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/categories?post=20333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/synektik.jcd.pl\/en\/wp-json\/wp\/v2\/tags?post=20333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}